Revenue | ₹66.52Cr |
Net Profits | ₹-4.39Cr |
Net Profit Margins | -6.60% |
Bharat Parenterals Ltd’s revenue fell -11.55% since last year same period to ₹66.52Cr in the Q3 2025-2026. On a quarterly growth basis, Bharat Parenterals Ltd has generated -2.39% fall in its revenue since last 3-months.
Bharat Parenterals Ltd’s net profit fell -162.87% since last year same period to ₹-4.39Cr in the Q3 2025-2026. On a quarterly growth basis, Bharat Parenterals Ltd has generated 39.28% jump in its net profits since last 3-months.
Bharat Parenterals Ltd’s net profit margin fell -197.22% since last year same period to -6.60% in the Q3 2025-2026. On a quarterly growth basis, Bharat Parenterals Ltd has generated 37.79% jumped in its net profit margins since last 3-months.
The revenue for Bharat Parenterals Ltd in the Q3 results 2025 was ₹66.52Cr.
The net profit for Bharat Parenterals Ltd in the Q3 results 2025 was ₹-4.39Cr.
The net profit margin for Bharat Parenterals Ltd in the Q3 results 2025 was -6.60%.
The revenue for Bharat Parenterals Ltd in the Q3 results 2024 was ₹75.21Cr.
The net profit for Bharat Parenterals Ltd in the Q3 results 2024 was ₹-1.67Cr.
The net profit margin for Bharat Parenterals Ltd in the Q3 results 2024 was -2.22%.